PHILADELPHIA--(BUSINESS WIRE)--April 13, 2006--Hemispherx Biopharma, Inc.: Dear Shareholders, I would like to take this opportunity to review what has been accomplished in the 1st Quarter of 2006 and lay out for you some of the objectives targeted for the rest of the year. The initial results of three avian influenza related studies initiated in the summer of 2005 were presented at two conferences, the ASM Biodefense Research Meeting in Washington, D.C. and the VIII International Symposium on Respiratory Viral Infections in Hawaii.
